[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630917":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":25,"locations":26,"responsibleParty":47,"collaborators":25,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":25,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":25,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":71,"overallStatus":29,"whyStopped":25,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"\"Tongguan Liqiao\" Acupuncture Group","EXPERIMENTAL","The Tongguan Liqiao acupuncture technique developed by Academician Xuemin Shi is employed. The procedure follows the SCM 88-2025 International Standard for Traditional Chinese Medicine Techniques: Tongguan Liqiao Acupuncture for PSD.",[13],"Procedure: acupuncture",{"label":15,"type":16,"description":17,"interventionNames":18},"Conventional Acupuncture Group","ACTIVE_COMPARATOR","Each research unit (sub-center) shall strictly adhere to the \"protocol plan\" designated for routine use. Once specified, the protocol plan shall not be altered and must be executed in strict accordance with its provisions.",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"PROCEDURE","acupuncture","Tongguan Liqiao Acupuncture Group： ①Acupoint Selection The treatment is phased, combining main and adjunct points. Main points: Neiguan (PC6), Shuigou (GV26), Sanyinjiao (SP6). Adjunct points: Fengchi (GB20), Wangu (GB12), Yifeng (TE17).\n\nTreatment is phased, combining primary and auxiliary points.\n\n② Location and Operation Point locations follow the 2006 National Standard of the People's Republic of China (GB\u002FT12346-2006) \"Acupoint Names and Locations.\" Manipulation follows the SCM 88-2025 International Standard for Traditional Chinese Medicine Techniques: Acupuncture Method for Tongguan Liqiao to Treat Post-Stroke Dysphagia.\n\nConventional Acupuncture Group： The \"protocol scheme\" habitually applied by each research unit (sub-center). Once designated, the protocol scheme shall not be altered and must be strictly adhered to.",[9,15],null,[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Xiaonong Fan","RECRUITING","Tianjin","Tianjin Municipality","300193","China","CN",{"type":36,"coordinates":37},"Point",[38,39],117.17667,39.14222,{"lat":39,"lon":38},[42],{"name":43,"role":44,"phone":45,"phoneExt":25,"email":46},"Xiaonong Fan, PhD","CONTACT","13902080823","fanxiaonong@163.com",{"type":48,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Yuzheng Du","Chief Physician","100630917","acupuncture-for-post-stroke-dysphagia-a-clinical-study-100630917",false,"NCT07493902","Acupuncture for Post-Stroke Dysphagia: A Clinical Study","Acupuncture Treatment for Post-Stroke Dysphagia: A Prospective, Multicenter Clinical Study of a Cohort-Based Embedded Partially Randomized Preference Trial","Inclusion Criteria:\n\n* Age between 18 and 80 years old, no gender restrictions;\n\n  * Meets diagnostic criteria for ischemic or hemorrhagic stroke, confirmed by CT or MRI, with disease duration within one year;\n\n    * Meets diagnostic criteria for dysphagia, with FOIS grade 2-4;\n\n      * Vital signs stable, able to understand and cooperate with study procedures; ⑤ Patient or legal representative agrees to sign informed consent.\n\nExclusion Criteria:\n\n* Dysphagia not caused by stroke, but resulting from other neurological disorders (e.g., motor neuron disease, myasthenia gravis) or organic lesions (e.g., tumors);\n\n  * Patients with psychiatric disorders or severe cognitive impairment who cannot cooperate with treatment;\n\n    * Patients with an expected survival time of less than 3 months; ④ Individuals with contrast medium allergy;\n\n      * Patients with severe needle phobia who cannot tolerate the procedure; ⑥ Pregnant women, those planning pregnancy, or lactating women; ⑦ Individuals who have participated in other clinical trials or received acupuncture within the past week.","ALL","18 Years","80 Years",{"count":62,"type":63},3232,"ESTIMATED","INTERVENTIONAL",[66],"NA","Employing a nested design, a partially randomized preference study (Study II) is embedded within a prospective, multicenter cohort study (Study I). The cohort study, with acupuncture as the exposure factor, explores the clinical efficacy and health economic value of different integrated Chinese and Western medicine treatment protocols. The nested partially randomized preference study of different acupuncture protocols generates high-level evidence through randomized cohorts while supplementing real-world decision-making with preference cohort data.",[69,70],"Post-stroke Dysphagia","Acupuncture",[72,22],"post-stroke dysphagia","2026-03-20",{"date":75,"type":76},"2026-03-25","ACTUAL",{"date":78,"type":63},"2026-04",{"date":80,"type":63},"2028-04",{"name":5,"class":6},1]